Results 221 to 230 of about 28,926,907 (345)
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
Time to First Injury After Knee Surgery in U.S. Army Soldiers: A Survival Analysis. [PDF]
Adams BG +3 more
europepmc +1 more source
Table7_High-Dimensional Mediation Analysis Based on Additive Hazards Model for Survival Data.pdf
Yidan Cui (122081) +3 more
openalex +2 more sources
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Incidence trends and survival analysis of enteropathy-associated T-cell lymphoma. [PDF]
Xiang L, Pan T, Man X, Zhuang Q.
europepmc +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source

